
Diabetes Drug Shows Promise in Preventing Dementia.
A study in the Neurology journal suggests that the diabetes drug pioglitazone may reduce dementia risk in newly diagnosed type 2 diabetics, with benefits amplified in those with a history of ischemic heart disease or stroke. However, the drug’s potential side effects call for further research into its long-term safety and effectiveness.


